or Try an Advanced Search...

    Technical Analysis for CABA - Cabaletta Bio, Inc.

    Grade Last Price % Change Price Change
    F 11.01 -9.61% -1.17
    CABA closed down 9.61 percent on Friday, April 26, 2024, on 2.85 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 9
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical CABA trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion -9.61%
    Gapped Down Weakness -9.61%
    Lower Bollinger Band Touch Weakness -9.61%
    Oversold Stochastic Weakness -9.61%
    Older End-of-Day Signals for CABA ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR 2 days ago
    Fell Below Lower Bollinger Band 2 days ago
    Down 5% 2 days ago
    Fell Below Previous Day's Low 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CABA Chart by TradingView
    Basic chart:

    Profile

    Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Immunology Antibodies Autoimmune Disease Autoimmunity T Cell Sjögren Syndrome

    Is CABA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 23 Cabaletta Bio Inc (CABA) Earnings: Aligns with EPS Projections, Forecasts Extended Cash Runway
    Mar 21 Cabaletta Bio files automatic mixed securities shelf
    Mar 21 Cabaletta Bio GAAP EPS of -$0.46
    Mar 21 Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    Mar 20 Cabaletta gets FDA orphan drug status for systemic sclerosis drug
    Mar 20 Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
    Mar 8 Jim Cramer’s 10 Latest Stock Picks This Week
    Mar 6 Cramer: This REIT Is 'A Little Too Dicey'; As For Marathon Digital, 'Own The Pure'
    Feb 27 Several Factors Led to the Outperformance of Cabaletta Bio (CABA) in Q4
    Feb 27 Cabaletta Bio to Participate in Upcoming Investor Conferences in March
    See more CABA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.35
    52 Week Low 9.02
    Average Volume 1,024,628
    200-Day Moving Average 17.27
    50-Day Moving Average 18.62
    20-Day Moving Average 15.51
    10-Day Moving Average 13.77
    Average True Range 1.13
    RSI (14) 18.70
    ADX 34.72
    +DI 10.72
    -DI 39.83
    Chandelier Exit (Long, 3 ATRs) 15.64
    Chandelier Exit (Short, 3 ATRs) 14.39
    Upper Bollinger Bands 19.82
    Lower Bollinger Band 11.20
    Percent B (%b) -0.02
    BandWidth 55.52
    MACD Line -1.80
    MACD Signal Line -1.44
    MACD Histogram -0.3635
    Fundamentals Value
    Market Cap 471.77 Million
    Num Shares 42.8 Million
    EPS -1.70
    Price-to-Earnings (P/E) Ratio -6.48
    Price-to-Sales 0.00
    Price-to-Book 6.65
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.98
    Resistance 3 (R3) 13.19 12.74 12.65
    Resistance 2 (R2) 12.74 12.24 12.64 12.54
    Resistance 1 (R1) 11.88 11.93 11.66 11.67 12.43
    Pivot Point 11.43 11.43 11.32 11.33 11.43
    Support 1 (S1) 10.57 10.93 10.35 10.36 9.59
    Support 2 (S2) 10.12 10.62 10.02 9.48
    Support 3 (S3) 9.26 10.12 9.37
    Support 4 (S4) 9.05